We are live on ! Find out more
JA

JLB & Associates Portfolio holdings

AUM $696M
1-Year Est. Return 17.86%
This Fund
S&P 500
This Quarter Est. Return
+2.24%
1 Year Est. Return
+17.86%
3 Year Est. Return
+57.72%
5 Year Est. Return
+93.63%
10 Year Est. Return
AUM
$279M
AUM Growth
+$3.52M
Cap. Flow
-$502K
Cap. Flow %
-0.18%
Top 10 Hldgs %
30.61%
Holding
75
New
1
Increased
23
Reduced
42
Closed

Sector Composition

1 Technology 18.84%
2 Healthcare 16.98%
3 Consumer Discretionary 16.76%
4 Industrials 13.7%
5 Consumer Staples 11.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
1
Gilead Sciences
GILD
$174B
$11.8M 4.22%
110,470
-7,314
-6% -$716K
MA icon
2
Mastercard
MA
$485B
$9.18M 3.29%
124,185
+636
+0.5% +$48.4K
ORCL icon
3
Oracle
ORCL
$358B
$8.87M 3.18%
231,716
-420
-0.2% -$17K
MSFT icon
4
Microsoft
MSFT
$2.92T
$8.48M 3.04%
183,038
-1,060
-0.6% -$47.3K
NEU icon
5
NewMarket
NEU
$7.14B
$8.16M 2.93%
21,431
-53
-0.2% -$21K
AAPL icon
6
Apple
AAPL
$4.87T
$8.06M 2.89%
320,208
+1,340
+0.4% +$32.9K
MKC icon
7
McCormick & Company Non-Voting
MKC
$14.4B
$7.99M 2.86%
238,758
+2,296
+1% +$79K
PII icon
8
Polaris
PII
$4.24B
$7.7M 2.76%
51,404
-250
-0.5% -$36.1K
CTSH icon
9
Cognizant
CTSH
$21.3B
$7.61M 2.73%
170,026
-165
-0.1% -$7.76K
APH icon
10
Amphenol
APH
$182B
$7.56M 2.71%
605,560
-11,024
-2% -$138K
AME icon
11
Ametek
AME
$54B
$7.5M 2.69%
149,301
-2,228
-1% -$116K
ACN icon
12
Accenture
ACN
$88.9B
$7.46M 2.67%
91,721
-77
-0.1% -$6.17K
PEP icon
13
PepsiCo
PEP
$193B
$7.22M 2.59%
77,572
-309
-0.4% -$28.2K
SEIC icon
14
SEI Investments
SEIC
$12.1B
$6.7M 2.4%
185,253
+1,800
+1% +$64.1K
GGG icon
15
Graco
GGG
$12.7B
$6.68M 2.39%
274,605
-339
-0.1% -$8.58K
NKE icon
16
Nike
NKE
$66.5B
$6.63M 2.38%
148,654
-1,630
-1% -$64.7K
OA
17
DELISTED
Orbital ATK, Inc.
OA
$6.05M 2.17%
47,434
-1,902
-4% -$249K
AMGN icon
18
Amgen
AMGN
$204B
$5.91M 2.12%
42,045
+1,127
+3% +$147K
ROST icon
19
Ross Stores
ROST
$75.8B
$5.85M 2.1%
154,914
-1,540
-1% -$53.6K
ROL icon
20
Rollins
ROL
$22.2B
$5.85M 2.1%
673,961
+331
+0% +$2.9K
BCR
21
DELISTED
CR Bard Inc.
BCR
$5.72M 2.05%
40,099
+75
+0.2% +$11.1K
VAR
22
DELISTED
Varian Medical Systems, Inc.
VAR
$5.66M 2.03%
80,518
-426
-0.5% -$31.4K
SYK icon
23
Stryker
SYK
$126B
$5.61M 2.01%
69,414
-635
-0.9% -$52.2K
TJX icon
24
TJX Companies
TJX
$173B
$5.55M 1.99%
187,580
+5,046
+3% +$142K
TTC icon
25
Toro Company
TTC
$9.19B
$5.49M 1.97%
185,280
+480
+0.3% +$14.6K

Similar funds

JLB & Associates's Q3 2014 Portfolio in Review

As of Q3 2014, JLB & Associates held 75 positions worth $279M, up 1.3% from $275M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Trading was light in Q3 2014: portfolio turnover was 1.3%. JLB & Associates opened 1 new position and made no exits, leaving the 75-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • JLB & Associates's largest Q3 2014 buy was Packaging Corp of America: 7,851 shares worth $501K.
  • JLB & Associates added most to Keurig Dr Pepper in Q3 2014, an estimated $764K increase.
  • JLB & Associates's biggest Q3 2014 reduction was Gilead Sciences, cutting an estimated $716K.
  • JLB & Associates's ten largest holdings make up 31% of its $279M portfolio in Q3 2014.
  • JLB & Associates opened 1 new position and closed 0 in Q3 2014.
  • JLB & Associates's portfolio value rose 1.3% quarter-over-quarter to $279M.

Based on JLB & Associates's 13F filing for Q3 2014, filed 7 Oct 2014.